StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
002100.SZ$6.38-3.92%
Fair $6.38+0.0%

002100.SZ

TECON BIOLOGY Co.LTD

Consumer Defensive / Packaged FoodsShenzhen

$6.38

-0.26 (-3.92%)

Fairly Valued+0.0%Fair Value $6.38Fund rank 23/100 · Data gapFallback financials|
SA 27/D
F-Score: 4/9
Declining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $535.4M · quality 33.7/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 13/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

27/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 2 consecutive years ROE is 3.0%, below the 5% threshold
Thesis & Journal · 002100.SZLocal privado en este navegador · TECON BIOLOGY Co.LTD
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$8.7B

P/E

42.5x

↑

EV/EBITDA

10.0x

↑

ROE

3.0%

↓

Gross Margin

9.9%

↓

Debt/Equity

0.92

↑
52-Week Range$6
$6$8

TradingView lightweight chart

002100.SZ price, volumen y niveles de valoración

Último $6.380Periodo +209.4%
Fair value: $6.380

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-0.0%

FCF CAGR

—

FCF margin

0.0%

FCF / Net income

0.01x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $16.98B · net income $210.6M · FCF $1.9M

2022-FY → 2025-FY

Gross margin

9.9%-0.3% pts

Operating margin

3.6%+0.0% pts

Net margin

1.2%-0.4% pts

FCF margin

0.0%+6.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$16.98B$16.98B$17.18B$19.03B$16.99B
Net Income$210.6M$210.6M$605.1M$-1.36B$280.8M
EBITDA$1.32B$1.32B$1.68B$-444.5M$1.17B
EPS0.150.150.44-1.010.21
Gross Margin9.9%9.9%12.1%2.9%10.1%
Operating Margin3.6%3.6%5.3%-3.7%3.5%
Net Margin1.2%1.2%3.5%-7.2%1.7%
Balance Sheet
Debt/Equity0.920.920.921.000.93
Current Ratio1.631.63———
Cash Flow
Free Cash Flow$1.9M$1.9M$535.4M$750.5M$-1.10B
Returns
ROE3.0%3.0%8.6%-21.3%3.5%
Valuation
P/E42.5342.5314.20—39.05
EV/EBITDA10.0410.047.13—12.81
P/B1.291.291.231.791.39
Growth & Yield
Revenue Growth-1.1%-1.1%-9.7%12.0%—
EPS Growth-65.9%-65.9%143.6%-581.0%—
Dividend Yield3.3%3.3%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

55.7%

muy exigente

EPS terminal req.

$0.57

Spread vs growth

-121.6%

5Y implied EPS CAGR

35.5%

muy exigente

EPS terminal req.

$0.69

Spread vs growth

-101.4%

10Y implied EPS CAGR

22.1%

exigente

EPS terminal req.

$1.10

Spread vs growth

-88.0%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +2.4%

Total return

+2.4%

Start / end P/E

14.6x → 42.5x

EPS bridge

0.44 → 0.15

Residual

-125.6%

EPS growth-65.9%
Multiple rerating+190.6%
Dividend+3.3%
Residual / FX / buybacks / cross-term-125.6%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.